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Abstract Parents of children with chronic disorders have an
impaired health-related quality of life (HRQoL) compared to
parents of healthy children. Remarkably, parents of children
with a metabolic disorder reported an even lower HRQoL than
parents of children with other chronic disorders. Possibly, the
uncertainty about the course of the disease and the limited life
expectancy in many metabolic disorders are important factors
in the low parental HRQoL. Therefore, we performed a cross-
sectional study in parents of children with phenylketonuria
(PKU, OMIM #261600) and galactosemia (OMIM #230400),
metabolic disorders not affecting life expectancy, in order to
investigate their HRQoL compared to parents of healthy
children and to parents of children with other metabolic
disorders. A total of 185 parents of children with PKU and
galactosemia aged 1–19 years completed two questionnaires.
Parents of children with PKU or galactosemia reported a
HRQoL comparable to parents of healthy children and a
significantly better HRQoL than parents of children with other
metabolic disorders. Important predictors for parental mental
HRQoL were the psychosocial factors emotional support and
loss of friendship. As parental mental functioning influences
the health, development and adjustment of their children, it is
important that treating physicians also pay attention to the
wellbeing of the parents. The insight that emotional support
and loss of friendship influence the HRQoL of the parents
enables treating physicians to provide better support for
these parents.
Introduction
In recent years, it has been demonstrated that parenting a
chronically ill child affects the quality of life of the care-
givers (Arafa et al. 2008; Klassen et al. 2008; Lawoko and
Soares 2003). Health-related quality of life (HRQoL) can
be viewed as the impact of illness and treatment on the
domains of physical, psychological, social and somatic
functioning and well-being (Revicki et al. 2000). Hatzmann
et al. (2008) reported a significantly lower HRQoL in
parents of children with chronic disorders compared to
parents of healthy children in the Netherlands. Within this
group of parents of chronically ill children, parents of
children with a metabolic disorder reported an even lower
HRQoL than parents of children with other chronic
diseases, such as end-stage renal disease or Duchenne
muscular dystrophy. Psychosocial determinants, like loss of
friendship and emotional support, proved to be important
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predictors for parental HRQoL (Hatzmann et al. 2009). The
children of the parents included in this previous study suffered
from urea cycle defects, organic acidurias, lysosomal storage
disorders and mitochondrial defects. In these metabolic
disorders, there is a great variety in life expectancy and
limited predictability of the course of the disease. This
uncertain outcome could be the reason for the lower parental
HRQoL in comparison to other chronic disorders. Phenylke-
tonuria (PKU, OMIM #261600) is an inborn error of
metabolism caused by a deficiency of the enzyme phenylal-
anine hydroxylase (PAH, EC 1.14.16.1). As a result of this
deficiency, the essential amino acid phenylalanine (Phe)
cannot be converted to tyrosine and accumulates in the body.
Untreated PKU results in severe intellectual disability and
neurological abnormalities (Scriver et al. 2008). Since the
instigation of newborn screening and early treatment with a
strict lifelong protein-restricted diet with supplementation of
amino acids, patients have an intellectual outcome within the
normal range but slightly below the population mean (Pietz
et al. 1998; Schmidt et al. 1996), and subtle neuropsycho-
logical deficits are reported (Moyle et al. 2007). Classical
galactosemia (OMIM #230400) is an autosomal recessive
disorder of galactose metabolism, caused by a deficiency of
the enzyme galactose-1-phosphate-uridyltransferase (GALT,
EC 2.7.7.12). Patients present after ingestion of galactose
with severe illness in the first weeks of life. With a galactose-
restricted diet patients have a normal life expectancy.
However, patients may still suffer long-term complications
such as problems of mental development, disorders of
speech, hypergonadotrophic hypogonadism and decreased
bone mineral density (Bosch 2006). As in other metabolic
disorders, parents play a pivotal role in the management of
childhood PKU and galactosemia, and in spite of a normal
life expectancy, both disorders still pose a heavy burden for
the families. In order to be able to adequately support the
parents of children with metabolic diseases, insight into the
determinants of their HRQoL problems is necessary. We
performed a cross-sectional study in parents of children with
PKU and galactosemia, metabolic disorders not affecting life
expectancy, in order to investigate the HRQoL compared to
parents of healthy children and to parents of children with
other metabolic disorders. Secondarily, we evaluated which
variables predominantly affect the HRQoL in parents of
children with PKU and galactosemia.
Methods
Participants
The participating medical centers invited parents of 148
patients with PKU and galactosemia. The DutchGalactosemia
Society and the Dutch PKU Society also sent out invitation
letters; the exact number is not accessible because the Dutch
PKU Society does not keep a registry so sent the letter to all
members. It is inevitable that some of the parents received an
invitation letter from the treating physician as well as from the
Dutch PKU Society and Dutch Galactosemia Society. For
privacy reasons, it was not possible to establish the exact
number of parents in which this was the case.
Parents of children with PKU and galactosemia were
invited by letter to participate via the treating physician of
their child in the Academic Medical Centers of Amsterdam,
Leiden, Maastricht and Groningen and via the Dutch PKU
Society and the Dutch Galactosemia Society. Participants
were enrolled in the study between December 2008 and
February 2009. Parents of children with PKU or galacto-
semia aged 1–19 years, who had been diagnosed at least
1 year before and who were able to complete questionnaires
in Dutch, were eligible for inclusion.
Data of parents of healthy children (n=434) as well as
data of parents of children with lysosomal storage diseases,
organic acidurias or mitochondrial respiratory chain defects
(n=108) were used as reference data. These data were
gathered in the Dutch Care-project (Hatzmann et al. 2008,
2009). Approval for this study was granted by the Ethical
Committee of the Academic Medical Center (AMC),
Amsterdam.
Procedure
Parents were invited through a letter in which they were
asked to send an email stating their wish to participate to
the investigator, after which both parents received a unique
code. With the unique code, parents could log into a study
website to complete the questionnaires. After 1 month, all
parents received a reminder letter and 1 week before
closure of the study website, parents received a reminder
email. All questionnaires were completed anonymously and
data could not be traced back to the individual parent.
Measures
Health-related quality of life (HRQoL)
HRQoL was assessed with the TNO-AZL Questionnaire for
Adult’s Health related Quality of Life (TAAQoL) (Bruil et
al. 2004). The questionnaire measures health status prob-
lems weighted by the impact of problems on well-being on
12 multi-item scales: gross and fine motor functioning,
cognitive functioning, sleep, pain, social functioning, daily
activities, sexuality, vitality, positive emotions, depressive
emotions, and aggressiveness. Each item consists of two
parts: the first part assesses the prevalence of a health
problem or limitation in the past month, the second part the
emotional response to the health problem or limitation.
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Answers were scored on 4-point scales. A single score is
attributed to each combination of an item assessing the
prevalence of a problem or limitation and the corresponding
emotional response. The scales vitality, positive emotions,
depressive emotions and aggressiveness only assess the
occurrence of the feelings in the past month. The raw scale
scores are converted to 0–100; higher scores indicating
better HRQoL. The validity and reliability of the TAAQoL
were satisfactory (Bruil et al. 2004).
Overall physical and mental HRQoL were assessed by
aggregation of all TAAQoL scale scores according to the
algorithm described by Ware and Kosinski (2001), which
leads to the so-called Physical Component Score (PCS) and
Mental Component Score (MCS). The relative contribution
of each TAAQoL scale to MCS and PCS was derived from
principal components analysis, non-orthogonal rotation
(Oblimin), based on the assumption that physical and
mental HRQoL are interdependent.
The TAAQoL instrument can be downloaded at http://
www.tno.nl/content.cfm?context=markten&content=pro
duct&laag1=189&laag2=169&item_id=1529
Socio-demographic, medical and psychosocial variables
Participating parents were requested to provide information
about socio-demographic, medical and psychosocial varia-
bles through a selection of items from a questionnaire used
in a previous study (Hatzmann et al. 2008). Variables were
selected by two physicians involved in the care for patients
with metabolic disorders, based on clinical relevance and
existing literature.
The questionnaire consists of the following items:
Socio-demographic variables: parental gender, age
(parent and child), parental chronic disease (yes/no),
parental educational level and parental country of birth.
Medical variables: disease development (improving,
progressive, relapsing, stable) in the previous year, use
of tube-feeding (yes/no); dependency on medical
equipment (yes/no); problems with interaction (yes/
no); and hours of sleep per night (child). Also, care
dependency (ranging from 0 to 8) was included,
defined as the number of life domains on which the
child needs care (physical, mobility, eating and
drinking, medication use, coping with devices, enter-
taining, contact with other children, education).
Psychosocial variables: emotional support was defined
as support from four groups of reference persons
(partner, family, friends or neighbors), each scored on
a 3-point scale with the following values: 0=no, 1=
more or less, 2=good, resulting in an overall score for
emotional support from 0 to 8; loss of friendship since
illness of child (yes/no), given up hobby since illness
of child (yes/no), job adjustment due to illness of child
(yes/no), and contact with fellow-sufferers (frequently/
often versus sometimes or never).
Statistics
The Statistical Package for Social Sciences (SPSS) Win-
dows version 16.0 was used for all the analyses. Firstly, it
was tested whether the four groups of parents (of children
with PKU, galactosemia, other metabolic disorders and
parents of healthy children) differed significantly on socio-
demographic characteristics, using χ2 tests or analyses of
variance (ANOVA). The significance level was set at 0.1.
Socio-demographic characteristics, including age of the
child, were included in the analyses in order to be able to
assess most accurately the effects of medical and psycho-
social characteristics on HRQoL.
Secondly, ANOVAs by group and gender were conducted
to test group differences on the TAAQoL scale scores. We
used a significance level of 0.001 in order to compensate for
multiple testing, since we made 66 pairwise comparisons. For
each TAAQoL scale, pairwise group differences were
performed by ANOVA with contrasts: healthy versus PKU,
galactosemia, and Lyso/Organ/Mitochon; Lyso/Organ/Mito-
chon versus PKU and Galactosemia; and PKU versus
galactosemia. It was not necessary to control for parental age
because there was no effect of age on the TAAQoL domains,
with the exception of Positive emotions.
Thirdly, linear mixed models analysis (Snijders and Bosker
2004) was performed to examine which socio-demographic,
medical and psychosocial variables were predictive of mental
HRQoL (MCS). Parents (first level) were treated as nested
within children (second level). PCS could not be fitted in a
linear mixed model because the residuals appeared not to be
normally distributed. The linear mixed models analyses were
performed separately for parents of children with PKU and
parents of children with galactosemia.
Because of the large number of predictor variables in
relation to the sample size, pre-selection of variables was
necessary. Tube-feeding, dependency on medical equipment
and given up hobby were excluded beforehand because of too
small numbers in one of the categories. The other variables
were selected for the final analysis if they proved to be
associated with the outcome (MCS), the probability level was
set at 0.2 in one of the following models, for PKU and/or
galactosemia: MCS predicted by (1) socio-demographic
variables, (2) medical variables or (3) psychosocial variables.
All pre-selected variables were entered into the final models.
The models for PKU and galactosemia were initially fitted
with a random intercept. However, for the parents of children
with PKU, there appeared not to be intercept variance so that
the model for these parents was fitted with a fixed intercept.
J Inherit Metab Dis (2011) 34:391–398 393
Table 1 Socio-demographic, medical and psychosocial characteristics
PKU Galactosemia Lyso, org, mitoch Healthy
Socio-demographic
Parental age **
Mean (SD) 40.7 (6.3) 42.5 (6.5) 41.5 (7.0) 43.7 (5.4)
Range 28.4–57.4 29.4–55.1 23.8–60.1 20.1–60.5
n 86 41 108 441
Age child
Mean (SD) 8.7 (5.0) 9.8 (5.1) 8.2 (4.5)
Range 1–19 1–19 1–18
n 109 65 108
Parental gender: % (n) **
Male 43.1 (50) 39.1 (27) 21.3 (23) 16.7 (74)
Female 56.9 (66) 60.9 (42) 78.7 (85) 83.3 (369)
Parental educational level : % (n) a
Low 25.0 (29) 23.2 (16) 23.4 (25) 20.8 (91)
Middle 39.7 (46) 33.3 (23) 42.1 (45) 38.2 (167)
High 35.3 (41) 43.5 (30) 34.6 (37) 41.0 (179)
Parental country of birth (Netherlands): % (n) * 94.0 (109) 85.5 (59) 95.4 (103) 86.0 (381)
Parental chronic disease (yes): % (n) 7.8 (9) 5.8 (4) 12.0 (13) 7.7 (34)
Medical b
Disease development: % (n)
Improving 26.7 (31) 24.6 (17) 16.7 (18)
Progressive 1.7 (2) 2.9 (2) 31.5 (34)
Relapsing 14.7 (17) 13.0 (9) 23.1 (25)
Stable 56.9 (66) 59.4 (41) 28.7 (31)
Tube-feeding (yes): % (n) 0.9 (1) 0 25.9 (28)
Dependency medical equipment (yes): % (n) 6.0 (7) 0 25.9 (28)
Problems making contact (yes): % (n) 4.3 (5) 13.0 (9) 56.3 (58)
Hours sleep per night
Mean (SD) 9.7 (1.5) 9.4 (1.7) 9.0 (2.7)
Range 5–12 3–13 1–13
n 116 69 101
Care dependency (0-8)
Mean (SD) 1.1 (1.1) 2.0 (1.8) 5.1 (2.3)
Range 0–5 0–7 0–8
n 116 69 108
Psychosocial (parent) b
Emotional support (0-8)
Mean (SD) 5.4 (1.8) 5.4 (1.5) 4.9 (1.7)
Range 0–8 1–8 1–8
n 116 69 108
Loss of friendship (yes): % (n) 11.2 (13) 20.3 (14) 55.6 (60)
Given up hobby (yes): % (n) 3.4 (4) 10.1 (7) 45.3 (49)
Job adjustment (yes): % (n) 21.6 (25) 34.8 (24) 25.9 (28)
Contact fellow sufferers (frequently/often): % (n) 12.1 (14) 27.5 (19) 38.9 (42)
Lyso lysosomal storage diseases, org organic acidurias, mitoch mitochondrial respiratory chain defects
*Groups differed significantly at p<0.01 according tot ANOVA or χ2 test by group
**Groups differed significantly at p<0.001 according tot ANOVA or χ2 test by group
a Highest level completed: Low Primary Education, Technical and Vocational Training, Lower and Middle General Secondary Education; Middle Middle
Vocational Education, Higher General Secondary Education, Pre-university Education; High Higher Vocational Education, University
b Differences between the groups not tested
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The standardized regression coefficients of the predictors
were considered to be fixed because adding random effects
did not result in improvement of the models at a significance
level of 0.01.
To facilitate interpretation of regression coefficients,
all continuous scores were transformed into standard
normal scores, expressing deviations from the overall
mean of the concerning parents. We considered stan-
dardized regression coefficients of 0.1 as small, 0.3 as
medium and 0.5 as large after Cohen (1988). For binary
coded predictor variables, regression coefficients of 0.2
can be considered small, 0.5 medium and 0.8 large.
Because of the explorative nature of the regression
analyses, we used a significance level of 0.05 and trends
(p<0.1) are also reported.
Results
Participants
A total of 185 parents completed the questionnaires; 116
parents of children with PKU and 69 parents of children
with galactosemia. Parents of at least 140 children with
PKU or galactosemia participated. Although an exact
response rate cannot be calculated, the number of
patients included is 41% of the estimated total number
of Dutch patients with PKU or galactosemia aged 1–
19 years. Table 1 shows the characteristics of the parents
and the children. Parental age of 58 participants was
unknown because of a missing question in a part of the
questionnaires.
Parental health related quality of life
According to ANOVAs by group and gender (and age),
HRQoL of parents of children with PKU or galactosemia
appeared not to differ from HRQoL in parents of healthy
children, while parents of children with other metabolic
disorders reported significantly worse (p<0.001) HRQoL
than the healthy control group on 9 out of the 12 TAAQoL
scales (Table 2). Parents of children with PKU reported a
better HRQoL than parents of children with other
metabolic disorders (p<0.001) in 8 out of 12 domains.
Parents of children with galactosemia reported a signifi-
cantly better HRQoL than parents of children with other
Table 2 Mean HRQoL scale scores (TAAQoL) and 95% confidence intervals of caregivers of children with metabolic disorders and caregivers of
healthy children
PKU n=115 Galactosemia n=69 Lyso, Org, Mitocha n=108 b Healthy n≈430 c
Mean 95% CI Mean 95% CI Meand 95% CI Mean 95% CI
Gross motor 96.5 94.7–98.3 81.9 b 77.7–86.2 88.0 86.0–89.9
Fine motor 96.3 92.7–99.8 94.1 91.3–96.9 96.9 96.0–97.7
Cognitive 82.7 78.7–86.7 81.4 75.1–87.8 68.9 a 63.6–74.2 78.9 76.5–81.2
Sleep 75.7 71.3–80.1 59.8 72.6–67.7 58.2 ab 52.7–63.7 70.7 68.3–73.0
Pain 78.3 74.6–82.0 74.5 68.7–80.2 62.1 ab 56.8–67.4 71.9 69.8–74.0
Social 84.1 80.7–87.5 84.2 80.1–88.4 70.9 abc 66.4–75.3 83.5 81.6–85.4
Daily activities 87.7 83.7–91.7 88.6 83.5–93.7 68.3 abc 63.0–73.7 85.3 83.2–87.3
Sexuality 84.6 80.1–89.1 86.2 80.5–92.0 70.6 abc 65.1–76.0 84.8 82.5–87.0
Vitality 63.8 59.1–68.4 62.0 56.9–67.0 47.7 abc 42.7–52.7 63.3 61.2–65.4
Pos. emotions 64.6 60.8–68.5 62.4 57.9–67.0 56.3 a 52.5–60.2 66.4 64.5–68.3
Depres. emotions 78.9 75.6–82.2 75.2 70.6–79.8 60.1 abc 56.2–64.0 78.6 76.8–80.4
Agressiveness 89.3 86.6–91.9 90.2 87.3–93.1 83.0 79.8–86.2 86.0 89.1–89.6
Note: the empty boxes indicate exclusion because of Cronbach’s α<0.60
a Lyso lysosomal storage diseases, org organic acidurias, mitoch mitochondrial respiratory chain defects
b For the scale Sexuality N=104
c n between 414 (Sexuality scale) and 433 (Depressive emotions scale)
* p<0.001
d Letters in this column, all significant at p<0.001:
a Lyso, Org, Mitoch versus healthy, according to ANOVA by group and gender; Positive Emotions: ANOVA by group, gender and parental age
b Lyso, Org, Mitoch versus PKU, according to ANOVA by group and gender
c Lyso, Org, Mitoch versus galactosemia, according to ANOVA by group and gender
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metabolic disorders (p<0.001) in 5 out of 12 domains. We
did not find any difference between parents of children
with PKU and galactosemia according to ANOVA at
p<0.001.
Predictors of mental HRQoL in parents of children
with PKU or galactosemia
Parameter estimates from the linear mixed model analyses
of parental mental HRQoL are shown in Table 3. The size
of most standardized regression coefficients was small to
medium.
Mental HRQoL (MCS) in parents of children with PKU
was affected significantly by the age of their child, emotional
support and loss of friendship. A higher age of the child (β=
0.21, p<0.05) and more emotional support (β=0.20, p<
0.05) was associated with a better MCS. Loss of friendship
was negatively associated with MCS (β=−1.2, p<0.001). In
addition, a trend was found for the effect of disease
development. Parents who considered the disease develop-
ment as stable in the previous year showed better MCS (β=
0.32, p=0.071).
MCS in parents of children with galactosemia was only
significantly affected by emotional support, which seemed
positively associated with MCS (β=0.38, p<0.001). In
addition, the results indicated that mothers experienced
worse MCS than fathers (β=−0.38, p=0.062), as did
parents who had adjusted their job since the illness of their
child (β=−0.41, p=0.072). Furthermore, a stable disease in
the previous year tended to be positively associated with
MCS (β=0.38, p=0.059).
Discussion
In this study, we demonstrate a normal HRQoL in
parents of children with PKU and galactosemia. This
finding is remarkable because both these disorders cause
a substantial burden on the family (Kazak et al. 1988)
and the HRQoL of the children with classical galactosemia
is severely hampered due to the long-term complications
that are seen in this disorder (Bosch et al. 2004). As we
expected, these parents do have a better outcome com-
pared to parents of children with other metabolic disorders
Table 3 Mental component scale scores (TAAQoL) of parents of children with PKU and Galactosemia predicted by demographic, medical and
psychosocial characteristics, in a multilevel linear model
PKU Galactosemia
Coefficient β SE of β 95% CI Coefficient β SE of β 95% CI
Fixed effects
Socio-demographic
Age child 0.21* 0.10 0.02; 0.41 −0.09 0.10 −0.29; 0.10
Parental gender (female) −0.17 0.16 −0.49; 0.15 −0.38b 0.20 −0.78; 0.02
Native country (Netherlands) 0.45 0.34 −0.22; 1.12 −0.07 0.29 −0.66; 0.51
Chronically ill −0.20 0.32 −0.83; 0.43 −0.17 0.43 −1.02; 0.68
Medical
Disease development (stable) 0.32a 0.17 −0.03; 0.66 0.38c 0.20 −0.02; 0.77
Care dependency −0.17 0.11 −0.40; 0.05 −0.07 0.10 −0.26; 0.12
Psychosocial
Emotional support 0.20* 0.09 0.02; 0.38 0.38** 0.10 0.17; 0.58
Loss of friendship −1.2** 0.32 −1.8; −0.52 0.06 0.28 −0.49; 0.62
Contact fellow sufferers 0.11 0.27 -0.41; 0.64 0.18 0.22 -0.25; 0.61
Job adjustment 0.09 0.22 -0.36; 0.53 −0.41d 0.22 -0.86; 0.04
% Explained variance by fixed effects 31.7 30.6
Total number of observations 109 65
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who, in a previous study, reported a severely hampered
HRQoL (Hatzmann et al. 2009). The main difference
between the patient groups in the present study and the
study by Hatzmann et al. (2009) is the difference in life
expectancy and predictability of the course of the disease,
which could well explain the differences in the HRQoL of
the parents. Furthermore, the differences between the
metabolic groups in terms of loss of friendship and giving
up hobbies as a result of the disease of the child should be
considered. Even though the findings show that parents of
children with PKU and galactosemia have a normal
HRQoL, the potential difficulties these parents experience
should not be underestimated.
The strength of this study is the high response rate
which might suggest that the respondents are a reliable
representation of the total of parents of children with
PKU and galactosemia. However, we do not have
demographic information of the non-responders, and the
respondents were for the most part mothers, although a
higher percentage of fathers responded compared to both
the group of parents of healthy children and the group of
parents of children with other metabolic disorders. To
attain a more complete picture of parental HRQoL, a
more thorough exploration of the HRQoL of fathers is
preferable.
In our study, psychosocial determinants like emotional
support and loss of friendship were predictive for parental
mental HRQoL, which has been reported before in other
chronic disorders including metabolic disorders (Hatzmann
et al. 2008, 2009). Furthermore, a higher age of the child
was associated with a better parental mental HRQoL in
parents of children with PKU. There are several possible
explanations for this phenomenon. Firstly, younger children
tend to need more care than older children, which can be a
burden to parents. Secondly, when the child is very young,
parents still need to get used to the protein-restricted diet of
their children, and thirdly, parents may be more uncertain
about how well the child will develop and what the
consequences for the future may be.
Children with chronic disorders are vulnerable to
develop adjustment problems when compared to their
healthy peers (Wallander and Varni 1998; Pless and Nolan
1991). Furthermore, parental mental functioning influences
the health, development and adjustment of their children
(Prince et al. 2007; Friedman et al. 2004). Therefore, it is
important that physicians involved in the care of children
with a chronic disorder also pay attention to the well-being
of the parents. The insight that emotional support and loss
of friendship influence the HRQoL of parents of children
with PKU and galactosemia enables treating physicians to
provide parents adequate support. Parents need to be
advised to be on the alert for loss of friendships and
emotional support and to maintain their social network, as
this might have consequences for their HRQoL. Parents at
risk for HRQoL impairment should be referred to social
work and psychosocial care to take a survey of the
problems and to empower parents to set up or maintain an
adequate support system.
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